[go: up one dir, main page]

MX2018006416A - Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina. - Google Patents

Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.

Info

Publication number
MX2018006416A
MX2018006416A MX2018006416A MX2018006416A MX2018006416A MX 2018006416 A MX2018006416 A MX 2018006416A MX 2018006416 A MX2018006416 A MX 2018006416A MX 2018006416 A MX2018006416 A MX 2018006416A MX 2018006416 A MX2018006416 A MX 2018006416A
Authority
MX
Mexico
Prior art keywords
methods
treating
preventing
virus infection
diarrhea virus
Prior art date
Application number
MX2018006416A
Other languages
English (en)
Inventor
Gerdts Volker
Allan Brenda
Van Den Hurk Jan
Zhou Yan
Zakhartchouk Alexander
Tikoo Suresh
Potter Andrew
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of MX2018006416A publication Critical patent/MX2018006416A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G01N2333/17—Porcine transmissible gastroenteritis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a inmunógenos, composiciones y métodos para el tratamiento, prevención y/o diagnóstico de infección por VDEP en cerdos. Las composiciones y métodos utilizan vacunas que contienen virus atenuados o inactivados, o subunidades de vacuna, incluyendo inmunógenos y mezclas de inmunógenos derivados de aislamientos del VDEP.
MX2018006416A 2015-11-25 2016-11-24 Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina. MX2018006416A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562260128P 2015-11-25 2015-11-25
US201662382395P 2016-09-01 2016-09-01
PCT/CA2016/051381 WO2017088060A1 (en) 2015-11-25 2016-11-24 Methods for treating, preventing and diagnosing porcine epidemic diarrhea virus infection

Publications (1)

Publication Number Publication Date
MX2018006416A true MX2018006416A (es) 2018-11-09

Family

ID=58762804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006416A MX2018006416A (es) 2015-11-25 2016-11-24 Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.

Country Status (9)

Country Link
US (1) US20180344836A1 (es)
EP (1) EP3380494A4 (es)
BR (1) BR112018010679A8 (es)
CA (1) CA3004931A1 (es)
HK (1) HK1259323A1 (es)
MX (1) MX2018006416A (es)
RU (1) RU2018123005A (es)
TW (1) TW201731525A (es)
WO (1) WO2017088060A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108486067B (zh) * 2018-02-11 2022-03-15 黑龙江正康生物技术股份有限公司 猪流行性腹泻病毒变异株及其制备的灭活疫苗和应用
CN109337876A (zh) * 2018-10-15 2019-02-15 北京世纪元亨动物防疫技术有限公司 一种猪流行性腹泻病毒的纯化方法
EP3897710A1 (en) 2018-12-20 2021-10-27 Intervet International B.V. Prime-boost vaccination regimen
BR112021017099A2 (pt) * 2019-02-28 2021-11-03 Univ Saskatchewan Composições de lawsonia intracellularis e métodos para uso das mesmas
CN111474346B (zh) * 2020-04-15 2023-07-11 浙江理工大学绍兴生物医药研究院有限公司 猪流行性腹泻病毒IgA和IgG抗体检测试剂盒及其制备方法和应用
CN112415207B (zh) * 2020-10-27 2022-04-12 中国农业科学院兰州兽医研究所 一种基于抗猪流行性腹泻病毒变异毒株重组S2蛋白的IgA抗体ELISA检测试剂盒
CA3166564A1 (en) * 2021-07-08 2023-01-08 Academia Sinica Recombinant antibody and uses thereof
CN115466317B (zh) * 2022-06-16 2025-12-05 广西大学 基于pedv orf3重组蛋白制备的多克隆抗体及建立的间接elisa检测方法
CN120082601B (zh) * 2025-05-07 2025-08-22 江苏省农业科学院 一种低复制能力的猪流行性腹泻病毒及其构建方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009304552B2 (en) * 2008-10-16 2015-02-19 Dalhousie University Combination adjuvant formulation
CN103675274B (zh) * 2013-12-17 2016-03-30 广西大学 检测猪流行性腹泻病毒抗体的间接elisa试剂盒
JP6395855B2 (ja) * 2014-04-03 2018-09-26 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド ブタ流行性下痢ウイルスワクチン
US9713639B2 (en) * 2014-05-19 2017-07-25 Merial, Inc. Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
RS62414B1 (sr) * 2014-07-11 2021-10-29 Zoetis Services Llc Nove kompozicije vakcine za virus svinjske epidemijske dijareje
CN104262488B (zh) * 2014-09-24 2017-07-28 普莱柯生物工程股份有限公司 一种融合蛋白及其疫苗组合物的制备与应用

Also Published As

Publication number Publication date
CA3004931A1 (en) 2017-06-01
BR112018010679A8 (pt) 2019-02-26
EP3380494A1 (en) 2018-10-03
TW201731525A (zh) 2017-09-16
EP3380494A4 (en) 2019-11-13
RU2018123005A3 (es) 2020-04-09
WO2017088060A1 (en) 2017-06-01
HK1259323A1 (zh) 2019-11-29
RU2018123005A (ru) 2019-12-25
US20180344836A1 (en) 2018-12-06
BR112018010679A2 (pt) 2018-11-13

Similar Documents

Publication Publication Date Title
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
EA201691993A1 (ru) Вакцина к вирусу эпидемической диареи свиней
PH12020500080A1 (en) Senecavirus a immunogenic compositions and methods thereof
MX2016016722A (es) Coronavirus.
PH12016502468B1 (en) Influenza virus vaccines and uses thereof
PH12018501602A1 (en) Subunit immersion vaccines for fish
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
MX2017000394A (es) Vacunas para virus influenza y usos de las mismas.
PL3103866T3 (pl) Sposób atenuowania świńskiego wirusa wścieklizny rzekomej, szczepy wirusowe atenuowane w ten sposób, kompozycja szczepionki i jej zastosowanie
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MY183072A (en) Methods and compositions for inducing protective immunity against filovirus infection
MY179251A (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
DK3501535T5 (da) Profylaktisk eller terapeutisk fremgangsmåde til svinepidemi-diarrévirus, vaccine og vaccinekit
PH12021551816A1 (en) Inactivated apxia, apxiia and apxiiia toxins
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
MX366263B (es) Parvovirus porcino 5b, metodos de uso y vacuna.
EA201792593A1 (ru) Пестивирусные вакцины против врожденного тремора
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
PH12017550047B1 (en) Use of taurine in prevention and/or treatment of diseases induced by viruses of genus coronavirus and/or genus rotavirus
BR112016012393A2 (pt) Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado
MX2014001158A (es) Virus recombinantes de influenza porcina y usos del mismo.
EA202090236A1 (ru) Иммуногенные композиции senecavirus a и способы с ними
EA201992167A1 (ru) Вакцина
BR112018013387A2 (pt) vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit
ZA201700164B (en) Influenza virus vaccines and uses thereof